Mark Sirgo

Mark Sirgo has a diverse and extensive work experience in the biotechnology and pharmaceutical industry. Mark is currently serving as the Chief Executive Officer of Corium Innovations, a position they have held since January 2023. Prior to that, they were the Chairman of the Board at Genenta Science and 9 Meters Biopharma, Inc. Mark also founded and operated PCS, LLC., a sole proprietorship where they assisted biotechnology companies in developing business plans and raising capital. In addition, Mark has held various positions in several other organizations, including Director of BioDelivery Sciences International, Director of Salix Pharmaceuticals, and Senior Vice President of Business Development at PPD. Mark began their career at GlaxoSmithKline as Vice President of Clinical Development.

Mark Sirgo has a Bachelor's degree in Pharmacy from The Ohio State University. Mark also has a Doctorate in Pharmacy from the University of the Sciences in Philadelphia.